| 2024-11-13 |
Adalimumab induced CNS demyelination in a patient with multiple pre-existing autoimmune diseases; treatment contemplation |
Sepehr Khosravi |
|
| 2024-11-13 |
Maintaining good mental health in people with inflammatory arthritis: a qualitative study of patients' perspectives |
Signe Marie Abild |
|
| 2024-11-13 |
Patient and public involvement in the design of an international clinical trial: real world experience |
Gwenda Simons |
|
| 2024-11-13 |
Validating Joint Acoustic Emissions Models as a Generalizable Predictor of Joint Health |
Kristine L Richardson |
|
| 2024-11-13 |
Atypical Periprosthetic Joint Infection Post-Total Knee Arthroplasty: A Case of Actinomyces europaeus |
Razvan Spiridonica |
|
| 2024-11-13 |
Is the development of arrhythmia predictable in rheumatoid arthritis? |
Arif Gülkesen |
|
| 2024-11-13 |
Apoptosis-associated genetic mechanisms in the transition from rheumatoid arthritis to osteoporosis: A bioinformatics and functional analysis approach |
Hao-Ju Lo |
|
| 2024-11-13 |
Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis? |
Rezan Koçak Ulucaköy |
|
| 2024-11-13 |
Comparison of creatine kinase elevation caused by Janus kinase inhibitors and interleukin-6 inhibitors in patients with rheumatoid arthritis: A propensity score-matched study |
Masahiro Tada |
|
| 2024-11-13 |
Osteoporosis knowledge and awareness among rheumatoid arthritis patients: A cross-sectional controlled study |
Öykü Tomay Aksoy |
|
| 2024-11-13 |
Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4 |
Yoshiya Tanaka |
|
| 2024-11-13 |
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study |
Xiaoting Shi |
|
| 2024-11-13 |
Association of Long-Term Exposure to PM(2.5) Constituents and Green Space With Arthritis and Rheumatoid Arthritis |
Yi-Sheng He |
|
| 2024-11-13 |
Neutrophil extracellular traps as immunofibrotic mediators in RA-ILD; pilot evaluation of the nintedanib therapy |
Aliki I Venetsanopoulou |
|
| 2024-11-13 |
Evaluation of the clinical performance of anti-mutated citrullinated vimentin antibody and 14-3-3 eta testing in rheumatoid arthritis |
Heather A Nelson |
|
| 2024-11-13 |
Sarcopenia and osteoporosis in patients with psoriatic arthritis: A single-center retrospective study |
Kenji Takami |
|
| 2024-11-13 |
Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment |
Kailash Prasad |
|
| 2024-11-13 |
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19 |
Yeon-Woo Heo |
|
| 2024-11-13 |
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey |
Mrinalini Dey |
|
| 2024-11-13 |
Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis |
Selinde V J Snoeck Henkemans |
|
| 2024-11-13 |
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung Disease |
Jacob Klein |
|
| 2024-11-13 |
Molecular mechanism through which Tripterygium hypoglaucum (Lévl.) Hutch alleviates psoriasis |
Yumei Sun |
|
| 2024-11-13 |
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential |
Shi-Zhi Hu |
|
| 2024-11-13 |
Pterocarya hupehensis Skan total flavones ameliorate rheumatoid arthritis in rats by suppressing formation of neutrophil extracellular traps |
R Yang |
|
| 2024-11-13 |
Prevalence of co-existing autoimmune and autoinflammatory diseases in vitiligo: a survey-based study from Egypt |
Samar Tharwat |
|
| 2024-11-13 |
Sjögren's syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody |
Hideki Nakamura |
|
| 2024-11-13 |
Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery |
Molly Klimak |
|
| 2024-11-13 |
Exploration the molecular mechanisms of Guizhi Shaoyao Zhimu Decoction (GSZD) in the treatment of rheumatoid arthritis via network pharmacology |
Ming Guo |
|
| 2024-11-13 |
Pooled safety analysis from the VOLTAIRE clinical trials of adalimumab-adbm and adalimumab reference product in patients with rheumatoid arthritis, Crohn's disease, and chronic plaque psoriasis |
Stanley Cohen |
|
| 2024-11-13 |
FOXO3 as a potential diagnostic biomarker for autophagy in rheumatoid arthritis: A bioinformatics study |
Qian Deng |
|
| 2024-11-13 |
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial |
Nageh A El-Mahdy |
|
| 2024-11-13 |
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors |
C Garufi |
|
| 2024-11-13 |
mHealth-Based Self-Management Program for Patients With Rheumatoid Arthritis: A Pilot Randomized Controlled Study |
Hyunjin Oh |
|
| 2024-11-13 |
Chronic Overlapping Pain Conditions and Nociplastic Pain |
Keira J A Johnston |
|
| 2024-11-13 |
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis |
Mauro Passari |
|
| 2024-11-13 |
Mechanism of Asperosaponin VI Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis |
Jin-Fang Luo |
|
| 2024-11-13 |
Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sjögren's syndrome via suppression of the CX3CL1/CX3CR1 axis |
Zi Yang |
|
| 2024-11-13 |
Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial |
Francoise Fayet |
|
| 2024-11-13 |
Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study |
Qian Lyu |
|
| 2024-11-13 |
Stable oxidative posttranslational modifications alter the gating properties of RyR1 |
Maarten M Steinz |
|
| 2024-11-13 |
Information and communication technology-based patient education for autoimmune inflammatory rheumatic diseases: A scoping review |
Junghee Yoon |
|
| 2024-11-13 |
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology |
Fabio Cacciapaglia |
|
| 2024-11-13 |
Rheumatoid arthritis associated recurrent pleural effusion |
Ramsha Abbas |
|
| 2024-11-13 |
Cyclin Dependent Kinase Inhibitor: A Long-Awaited, Late-Coming, Novel Class Agent in Rheumatoid Arthritis |
Tadashi Hosoya |
|
| 2024-11-13 |
Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis |
Katharine B Moosic |
|
| 2024-11-13 |
Predictors of the effectiveness to first-line CTLA4-Ig in patients with rheumatoid arthritis: the FIRST registry |
Hiroki Kobayashi |
|
| 2024-11-13 |
Genetically mimicked effects of thyroid dysfunction on diabetic retinopathy risk: a 2-sample univariable and multivariable Mendelian randomization study |
Junlin Ouyang |
|
| 2024-11-13 |
Evaluation of the potential of Ergostatrien-3β-ol for treating Sjögren's syndrome |
Po-Chang Wu |
|
| 2024-11-13 |
Prevalence and aggravation of cervical spine instabilities in rheumatoid arthritis during over 10 years: a prospective multicenter cohort study |
Yutaro Kanda |
|
| 2024-11-13 |
MSC-microvesicles protect cartilage from degradation in early rheumatoid arthritis via immunoregulation |
Shixiong Wei |
|
| 2024-11-13 |
Adalimumab induced CNS demyelination in a patient with multiple pre-existing autoimmune diseases; treatment contemplation |
Sepehr Khosravi |
|
| 2024-11-13 |
Maintaining good mental health in people with inflammatory arthritis: a qualitative study of patients' perspectives |
Signe Marie Abild |
|
| 2024-11-13 |
Patient and public involvement in the design of an international clinical trial: real world experience |
Gwenda Simons |
|
| 2024-11-13 |
Validating Joint Acoustic Emissions Models as a Generalizable Predictor of Joint Health |
Kristine L Richardson |
|
| 2024-11-13 |
Atypical Periprosthetic Joint Infection Post-Total Knee Arthroplasty: A Case of Actinomyces europaeus |
Razvan Spiridonica |
|
| 2024-11-13 |
Is the development of arrhythmia predictable in rheumatoid arthritis? |
Arif Gülkesen |
|
| 2024-11-13 |
Apoptosis-associated genetic mechanisms in the transition from rheumatoid arthritis to osteoporosis: A bioinformatics and functional analysis approach |
Hao-Ju Lo |
|
| 2024-11-13 |
Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis? |
Rezan Koçak Ulucaköy |
|
| 2024-11-13 |
Comparison of creatine kinase elevation caused by Janus kinase inhibitors and interleukin-6 inhibitors in patients with rheumatoid arthritis: A propensity score-matched study |
Masahiro Tada |
|
| 2024-11-13 |
Osteoporosis knowledge and awareness among rheumatoid arthritis patients: A cross-sectional controlled study |
Öykü Tomay Aksoy |
|
| 2024-11-13 |
Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4 |
Yoshiya Tanaka |
|
| 2024-11-13 |
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study |
Xiaoting Shi |
|
| 2024-11-13 |
Association of Long-Term Exposure to PM(2.5) Constituents and Green Space With Arthritis and Rheumatoid Arthritis |
Yi-Sheng He |
|
| 2024-11-13 |
Neutrophil extracellular traps as immunofibrotic mediators in RA-ILD; pilot evaluation of the nintedanib therapy |
Aliki I Venetsanopoulou |
|
| 2024-11-13 |
Evaluation of the clinical performance of anti-mutated citrullinated vimentin antibody and 14-3-3 eta testing in rheumatoid arthritis |
Heather A Nelson |
|
| 2024-11-13 |
Sarcopenia and osteoporosis in patients with psoriatic arthritis: A single-center retrospective study |
Kenji Takami |
|
| 2024-11-13 |
Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment |
Kailash Prasad |
|
| 2024-11-13 |
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19 |
Yeon-Woo Heo |
|
| 2024-11-13 |
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey |
Mrinalini Dey |
|
| 2024-11-13 |
Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis |
Selinde V J Snoeck Henkemans |
|
| 2024-11-13 |
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung Disease |
Jacob Klein |
|
| 2024-11-13 |
Molecular mechanism through which Tripterygium hypoglaucum (Lévl.) Hutch alleviates psoriasis |
Yumei Sun |
|
| 2024-11-13 |
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential |
Shi-Zhi Hu |
|
| 2024-11-13 |
Pterocarya hupehensis Skan total flavones ameliorate rheumatoid arthritis in rats by suppressing formation of neutrophil extracellular traps |
R Yang |
|
| 2024-11-13 |
Prevalence of co-existing autoimmune and autoinflammatory diseases in vitiligo: a survey-based study from Egypt |
Samar Tharwat |
|
| 2024-11-13 |
Sjögren's syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody |
Hideki Nakamura |
|
| 2024-11-13 |
Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery |
Molly Klimak |
|
| 2024-11-13 |
Exploration the molecular mechanisms of Guizhi Shaoyao Zhimu Decoction (GSZD) in the treatment of rheumatoid arthritis via network pharmacology |
Ming Guo |
|
| 2024-11-13 |
Pooled safety analysis from the VOLTAIRE clinical trials of adalimumab-adbm and adalimumab reference product in patients with rheumatoid arthritis, Crohn's disease, and chronic plaque psoriasis |
Stanley Cohen |
|
| 2024-11-13 |
FOXO3 as a potential diagnostic biomarker for autophagy in rheumatoid arthritis: A bioinformatics study |
Qian Deng |
|
| 2024-11-13 |
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial |
Nageh A El-Mahdy |
|
| 2024-11-13 |
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors |
C Garufi |
|
| 2024-11-13 |
mHealth-Based Self-Management Program for Patients With Rheumatoid Arthritis: A Pilot Randomized Controlled Study |
Hyunjin Oh |
|
| 2024-11-13 |
Chronic Overlapping Pain Conditions and Nociplastic Pain |
Keira J A Johnston |
|
| 2024-11-13 |
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis |
Mauro Passari |
|
| 2024-11-13 |
Mechanism of Asperosaponin VI Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis |
Jin-Fang Luo |
|
| 2024-11-13 |
Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sjögren's syndrome via suppression of the CX3CL1/CX3CR1 axis |
Zi Yang |
|
| 2024-11-13 |
Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial |
Francoise Fayet |
|
| 2024-11-13 |
Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study |
Qian Lyu |
|
| 2024-11-13 |
Stable oxidative posttranslational modifications alter the gating properties of RyR1 |
Maarten M Steinz |
|
| 2024-11-13 |
Information and communication technology-based patient education for autoimmune inflammatory rheumatic diseases: A scoping review |
Junghee Yoon |
|
| 2024-11-13 |
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology |
Fabio Cacciapaglia |
|
| 2024-11-13 |
Rheumatoid arthritis associated recurrent pleural effusion |
Ramsha Abbas |
|
| 2024-11-13 |
Cyclin Dependent Kinase Inhibitor: A Long-Awaited, Late-Coming, Novel Class Agent in Rheumatoid Arthritis |
Tadashi Hosoya |
|
| 2024-11-13 |
Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis |
Katharine B Moosic |
|
| 2024-11-13 |
Predictors of the effectiveness to first-line CTLA4-Ig in patients with rheumatoid arthritis: the FIRST registry |
Hiroki Kobayashi |
|
| 2024-11-13 |
Genetically mimicked effects of thyroid dysfunction on diabetic retinopathy risk: a 2-sample univariable and multivariable Mendelian randomization study |
Junlin Ouyang |
|
| 2024-11-13 |
Evaluation of the potential of Ergostatrien-3β-ol for treating Sjögren's syndrome |
Po-Chang Wu |
|
| 2024-11-13 |
Prevalence and aggravation of cervical spine instabilities in rheumatoid arthritis during over 10 years: a prospective multicenter cohort study |
Yutaro Kanda |
|
| 2024-11-13 |
MSC-microvesicles protect cartilage from degradation in early rheumatoid arthritis via immunoregulation |
Shixiong Wei |
|
